Revival Healthcare Capital LLC

Revival Healthcare Capital LLC serves pooled investment funds and institutional investors, providing discretionary investment management to private funds that primarily invest in equity and equity-oriented securities of medical device and diagnostics companies. As of December 31, 2025, Revival reported approximately $964 million in regulatory assets under management and generally provides manager-led advisory services to pooled vehicles rather than individual retail accounts.

The firm pursues a “Build-to-Buy” strategy that structures custom partnerships with strategic healthcare companies and emphasizes post-investment value creation, typically seeking board representation and contractual mechanisms tied to development milestones. Revival positions itself as a flexible capital partner across company life cycles, often targeting the ability to invest at least $50 million in each partnership and leveraging Operating Advisors, proprietary market intelligence, and co-investment or side‑car vehicles to execute its strategy.

Compared with many peers, Revival has engaged third‑party solicitation arrangements and discloses that it may pay third‑party promoters for investor referrals, a form of endorsement activity that the brochure says is compensated and disclosed to investors. The firm also highlights features that can be atypical for a manager of pooled funds: negotiated side‑letters that can alter fees or rights, the ability to form side‑car and co‑investment vehicles that may have different economics, and a joint‑venture arrangement in which investment discretion is shared with a sole fund investor.